U.S. Healthcare Services Stock News

In March 2026, Revolve Group, Inc. launched Revolve Los Angeles, its first namesake fashion house, debuting a XXS–XL collection priced around US$200–US$3,500 and sold exclusively on Revolve and FWRD. The move expands Revolve’s in-house brand portfolio into higher-end, couture-influenced ready-to-wear, potentially deepening customer engagement around luxury, Los Angeles-inspired fashion. Next, we’ll examine how Revolve Los Angeles, as a higher-end in-house label, could influence Revolve...

Earlier this month, Hess Midstream LP announced that its Board authorized a share repurchase program and entered into an agreement with JPMorgan Chase Bank to buy back up to US$42 million of Class A shares, funded through its existing revolving credit facility, with repurchased shares to be cancelled and final settlement expected by March 2026. This accelerated share repurchase arrangement not only reduces the public float but also underscores management’s willingness to use balance sheet...

In recent days, Moelis & Company reported strong Q4 earnings and highlighted its strongest coverage platform to date, with management emphasizing momentum and long-term value creation. At the same time, several major banks reiterated neutral views on Moelis, revealing a tension between upbeat internal commentary and cautious external assessments. Next, we'll examine how upbeat earnings alongside cautious analyst sentiment may influence Moelis' existing investment narrative around growth...

In early March 2026, U.S. Bancorp expanded its funding options with a series of new senior unsecured fixed-rate notes maturing between 2031 and 2046, while also declaring regular quarterly and semi-annual dividends on its common and multiple preferred share classes payable on April 15, 2026. The creation of a President of Emerging Affluent Wealth Management role, alongside fresh bond issuance and an updated universal shelf registration, points to a coordinated push to deepen relationships...

In recent days, Department of Justice documents revealed that Ubiquiti’s networking equipment was used for communications and surveillance on Jeffrey Epstein’s private island, drawing public and regulatory attention to the company’s role. This association creates a new layer of reputational and legal risk for Ubiquiti, complicating an investment story previously focused on balance sheet strength and earnings momentum. We’ll now examine how this emerging reputational and regulatory risk...

In recent days, Opendoor Technologies reported Q4 revenue that exceeded analyst expectations while guiding to a roughly 10% year-on-year revenue decline for Q1 and an adjusted EBITDA loss. Management highlighted progress in unit economics, growth of its low-capital Cash Plus offering, cost reductions, and a new 4.99% beta mortgage program that together point to an evolving, more flexible business model. Next, we’ll examine how Opendoor’s stronger-than-expected Q4 revenue and improved unit...

On March 10, 2026, Amalgamated Financial Corp reported fourth-quarter 2025 earnings with earnings per share of $0.91, matching analyst expectations, while quarterly revenue of $87.91 million modestly exceeded forecasts. On the same day, Executive Vice President and Chief Legal Officer Mandy Tenner sold 776 shares under a Rule 10b5-1 plan, adding to a year of insider selling that raises questions about how leadership is managing personal holdings alongside solid operating results. Next,...

Ascendis Pharma A/S recently reported two-year data from its pivotal ApproaCH Trial, showing that once-weekly TransCon CNP (YUVIWEL) maintained consistent improvements in growth and body proportionality in children with achondroplasia, with a generally well-tolerated safety profile and strong trial retention. These longer-term results reinforce YUVIWEL’s clinical profile shortly after its U.S. approval for pediatric achondroplasia and ahead of a key European regulatory decision expected...

Why the leadership reshuffle at Playtika Holding (PLTK) matters for shareholders Playtika Holding (PLTK) is reshaping its senior ranks, with long serving President and CFO Craig Abrahams set to depart on April 1, 2026, and responsibilities shifting to existing insiders. Board chair Robert Antokol will add the President role. Senior finance leader Tae Lee will step in as acting CFO after several years overseeing corporate finance and investor relations. See our latest analysis for Playtika...

Netskope (NTSK) is back in focus after launching its Netskope One AI Security suite, alongside fresh earnings results and new healthcare integrations that together highlight how it is positioning around enterprise AI security. See our latest analysis for Netskope. Despite the launch of Netskope One AI Security and new healthcare integrations, Netskope’s short term share price return has been mixed. The 7 day share price return is 20.75% and the 90 day share price return is 51.40%, which...

The Trump administration previously issued an executive order under the Defense Production Act directing Sable Offshore to restart its long-idled Santa Ynez offshore unit and associated California pipelines, aiming to bolster fuel supplies during the conflict with Iran. This federal push, alongside ongoing court challenges and questions over permitting and safety, has turned Sable Offshore into a high-profile test case for how far Washington can go in overriding state-level environmental...

H2O America recently completed a follow-on equity offering of US$608.70 million, issuing 11,484,824 common shares at US$53 each with a US$1.7225 discount per share to help fund an acquisition. At the same time, Baird initiated coverage on H2O America with an Outperform rating, signaling increased institutional attention just as the company raises fresh capital for expansion. Next, we’ll explore how this sizable equity raise to fund an acquisition could reshape H2O America’s previously...

Willis Towers Watson (WTW) shares are in focus after the company expanded its GB Affinity technology ecosystem through a partnership with Qover, targeting embedded insurance solutions that are integrated directly into customer journeys across multiple sectors. See our latest analysis for Willis Towers Watson. Despite the Qover partnership putting the focus on Willis Towers Watson’s technology capabilities, the shares trade at US$289.54 after a 12.2% decline in the 3 month share price return,...

InnovAge Holding (INNV) has just been upgraded to a higher Zacks rank, supported by rising earnings estimate revisions and a hammer chart pattern that points to improving sentiment and renewed attention on the stock. See our latest analysis for InnovAge Holding. At a share price of $8.39, InnovAge Holding has seen short term share price pressure, with a 7 day share price return of a 4.22% decline, alongside strong recent momentum reflected in a 90 day share price return of 51.17% and a 1 year...

Apollo Global Management has launched the CG Apollo Global Diversified Credit LTAF, a newly FCA‑authorized multi-sector private credit fund offering UK defined contribution schemes access to a diversified global credit portfolio in a semi-liquid format. This fund is the first sub-fund in Apollo’s broader Private Markets LTAF umbrella and extends its push to bring institutional-grade private market retirement solutions to defined contribution plans across the UK, US and Europe. We’ll now...

Why MBX Biosciences is on investors’ radar today MBX Biosciences (MBX) has attracted attention after a recent move in its share price, with the stock now around $28 following mixed short term returns, including a decline over the past month and a modest gain over the past 3 months. See our latest analysis for MBX Biosciences. That recent pullback, with a 30 day share price return of around 26% decline and year to date share price return of around 8% decline, contrasts sharply with a very...

Earlier in March 2026, AllianceBernstein Holding reported that preliminary assets under management rose to US$880 billion in February from US$875 billion in January, mainly due to market appreciation despite modest net outflows. The firm also reported that private markets assets under management reached US$82 billion, a year-over-year increase described as 18%, alongside more than US$140 billion in annual sales even as active equities saw net outflows. We’ll now consider how this fresh...

Event-driven snapshot of CBIZ CBIZ (CBZ) is on investors’ radar after recent share price volatility, with the stock showing negative returns over the past month and past 3 months, prompting fresh interest in how its fundamentals line up. See our latest analysis for CBIZ. At a share price of $26.12, CBIZ has seen momentum fade, with a 30 day share price return of 6.18% and a year to date share price return decline of 48.58%, contributing to a 63.27% drop in 1 year total shareholder return. If...

Infleqtion stock at a glance Infleqtion (INFQ) has drawn investor attention after a period of weaker recent returns, with the share price down 5.6% over the past day and 26.2% over the past month. See our latest analysis for Infleqtion. The recent 41.2% year-to-date share price return decline, including a 26.2% drop in the last 30 days, suggests momentum has been fading as investors reassess Infleqtion's risk and growth profile in quantum computing. If Infleqtion's recent swings have you...

In March 2026, Sensata Technologies announced its FaultBreak contactor, a next-generation high voltage switching and protection solution for electric vehicles, combining passive and resettable fuse functions to improve fault clearing, safety, and system simplicity. By merging fuse and contactor functions into a compact, resettable device that cuts component count by over half, FaultBreak aims to help automakers reduce system cost, weight, and complexity while enhancing EV safety and...

Li Auto Inc. recently reported fourth-quarter 2025 results showing revenue falling to CNY 28,775.42 million and net income dropping to CNY 6.52 million, alongside guidance for first-quarter 2026 that points to lower deliveries and total revenue year over year. At the same time, the company is reshaping its governance to meet updated Hong Kong Listing Rules, while betting heavily on new flagship models, artificial intelligence, and overseas expansion in 2026 to revive its weakened business...

Apellis Pharmaceuticals recently added Mikael Dolsten, M.D., Ph.D., former chief scientific officer of Pfizer, to its board of directors, bringing decades of high-level research and development leadership across major global drug makers. This appointment, alongside growing analyst interest in Apellis’s key products Empaveli and Syfovre, underscores how external experts view the company’s pipeline and commercial portfolio as increasingly relevant in rare kidney disease and eye care...

Expeditors International of Washington recently reported Q4 2025 results with earnings per share of US$1.49 and revenue of US$2.86 billion, both ahead of analyst forecasts despite year-on-year declines. The board also approved a new share repurchase program of up to US$3.00 billion, highlighting management’s willingness to return substantial capital to shareholders. Next, we’ll examine how the stronger-than-expected quarterly earnings reshape Expeditors International of Washington’s...

In March 2026, National Fuel Gas’s board approved a regular quarterly dividend of US$0.535 per share, payable on April 15, 2026, to shareholders of record as of March 31, 2026, with about 95.0 million common shares and no preferred stock outstanding. Alongside this dividend affirmation, shareholders backed all management proposals at the 2026 annual meeting, reinforcing confidence in the company’s governance, audit oversight, and long-running record of uninterrupted annual dividend...